← Leaderboards
Robert James Malcolm
Medical University Of South Carolina
$11,789,861
Attributed
$13,001,551
Total exposure
13
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–17$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$13,001,551 · 13
By mechanism
R01$6,180,340 · 4
K12$2,423,380 · 1
P50$1,942,856 · 2
U09$890,000 · 1
P20$848,660 · 1
N01$504,598 · 1
Top collaborators
- Kathleen Theresa Brady5 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Lori A Knackstedt$3,602,436
- Lindsay Squeglia$10,315,385
- Lisa M McTeague$3,489,113
- Kevin M Gray$28,834,568
- William Christopher Buchta$111,688
Others in their field
Top investigators on “Cocaine”
- Sten H Vermund · University Of Alabama At Birmingham$115,253,143
- Fred M Gordin · Social And Scientific Systems, Inc.$44,160,542
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$42,690,128
- Joel Gelernter · Washington University$34,364,949
- Michael A Nader · Emory University$33,226,167
- Shenghan Lai · University Of Miami Coral Gables$31,568,530
Research focus
CocaineClinical ResearchAddictionHuman SubjectResearch PersonnelClinical TrialsAlcohol DependenceRecruitment ActivityPharmaceutical PreparationsProgramsLaboratory StudyCuesCravingPreclinical StudyPlacebosPublishingEnsureNational Institute Of Drug AbuseAlcoholism /Alcohol AbuseMalePre-ClinicalBaseFemaleCommunities
Grant awards (41)
Clinical Scientists Training in Addictions at MUSC$484,676
K12 · FY2017 · DA
Clinical Scientists Training in Addictions at MUSC$484,676
K12 · FY2016 · DA
N-acetylcysteine for Relapse Prevention to Cocaine Use$370,013
R01 · FY2016 · DA · contact PI
Clinical Scientists Training in Addictions at MUSC$484,676
K12 · FY2015 · DA
N-acetylcysteine for Relapse Prevention to Cocaine Use$368,143
R01 · FY2015 · DA · contact PI
Clinical Scientists Training in Addictions at MUSC$484,676
K12 · FY2014 · DA
N-acetylcysteine for Relapse Prevention to Cocaine Use$373,750
R01 · FY2014 · DA · contact PI
Clinical Scientists Training in Addictions at MUSC$484,676
K12 · FY2013 · DA
N-acetylcysteine for Relapse Prevention to Cocaine Use$373,438
R01 · FY2013 · DA · contact PI
A Controlled Trial of NAC for Cocaine Dependence$375,783
R01 · FY2009 · DA · contact PI
CBT and Modafinil for Cocaine Addiction$366,879
R01 · FY2009 · DA · contact PI
CLINICAL CIRCUITRY UNDERLYING METHAMPHETAMINE ADDICTION$210,226
P20 · FY2009 · DA · contact PI
CBT and Modafinil for Cocaine Addiction$366,879
R01 · FY2008 · DA · contact PI
CLINICAL CIRCUITRY UNDERLYING METHAMPHETAMINE ADDICTION$213,100
P20 · FY2008 · DA · contact PI
CLINICAL CIRCUITRY UNDERLYING METHAMPHETAMINE CUE CRAVING AND CUE EXTINCTION$31,774
M01 · FY2008 · RR · contact PI
A Controlled Trial of NAC for Cocaine Dependence$436,108
R01 · FY2007 · DA · contact PI
CLINICAL CIRCUITRY UNDERLYING METHAMPHETAMINE ADDICTION$215,760
P20 · FY2007 · DA · contact PI
A Controlled Trial of NAC for Cocaine Dependence$442,207
R01 · FY2006 · DA · contact PI
CBT and Modafinil for Cocaine Addiction$353,579
R01 · FY2006 · DA · contact PI
CLINICAL CIRCUITRY UNDERLYING METHAMPHETAMINE ADDICTION$209,574
P20 · FY2006 · DA · contact PI
CBT and Modafinil for Cocaine Addiction$424,978
R01 · FY2005 · DA
A Controlled Trial of NAC for Cocaine Dependence$417,519
R01 · FY2005 · DA
SCIENTIFIC EVALUATION$300,000
U09 · FY2005 · DA
SCIENTIFIC EVALUATION$150,000
U09 · FY2005 · DA
SCIENTIFIC EVALUATION$140,000
U09 · FY2005 · DA
SAFETY, TOLERABILITY, AND CUE-REACTIVITY RESPONSES OF N-ACETYLCYSTEINE IN COCAI$55,133
M01 · FY2005 · RR
CBT and Modafinil for Cocaine Addiction$407,303
R01 · FY2004 · DA
SCIENTIFIC EVALUATION$300,000
U09 · FY2004 · DA
Safety, Tolerability, and Cue-Reactivity Responses of N-Acetyclsteine in Cocai$124,810
M01 · FY2004 · RR
CBT and Modafinil for Cocaine Addiction$379,499
R01 · FY2003 · DA
GABAPENTIN AND LORAZEPAM IN OUTPATIENT DETOXIFICATION$242,857
P50 · FY2002 · AA
CORE--SHARED SCIENTIFIC RESOURCES$242,857
P50 · FY2002 · AA
CORE--SHARED SCIENTIFIC RESOURCES$242,857
P50 · FY2002 · AA
GABAPENTIN AND LORAZEPAM IN OUTPATIENT DETOXIFICATION$242,857
P50 · FY2002 · AA
AMLODIPINE TREATMENT FOR COCAINE DEPENDENCE$346,824
R01 · FY2001 · DA
CORE--SHARED SCIENTIFIC RESOURCES$242,857
P50 · FY2001 · AA
GABAPENTIN AND LORAZEPAM IN OUTPATIENT DETOXIFICATION$242,857
P50 · FY2001 · AA
CLINICAL TRIAL OPERATIONS$504,598
N01 · FY2000 · DA
AMLODIPINE TREATMENT FOR COCAINE DEPENDENCE$377,438
R01 · FY2000 · DA
CORE--SHARED SCIENTIFIC RESOURCES$242,857
P50 · FY2000 · AA
CARBAMAZEPINE AND LORAZEPAM IN OUTPATIENT DETOXIFICATION$242,857
P50 · FY2000 · AA